JPS6168427A - 腫瘍治療剤およびその製法 - Google Patents

腫瘍治療剤およびその製法

Info

Publication number
JPS6168427A
JPS6168427A JP60195000A JP19500085A JPS6168427A JP S6168427 A JPS6168427 A JP S6168427A JP 60195000 A JP60195000 A JP 60195000A JP 19500085 A JP19500085 A JP 19500085A JP S6168427 A JPS6168427 A JP S6168427A
Authority
JP
Japan
Prior art keywords
therapeutic agent
cells
tumor
monoclonal antibodies
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60195000A
Other languages
English (en)
Japanese (ja)
Inventor
クラウス・ボスレツト
ハンス‐ハーラルト・ゼトラツエク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of JPS6168427A publication Critical patent/JPS6168427A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Window Of Vehicle (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
JP60195000A 1984-09-06 1985-09-05 腫瘍治療剤およびその製法 Pending JPS6168427A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3432714.2 1984-09-06
DE19843432714 DE3432714A1 (de) 1984-09-06 1984-09-06 Tumortherapeutikum und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
JPS6168427A true JPS6168427A (ja) 1986-04-08

Family

ID=6244749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60195000A Pending JPS6168427A (ja) 1984-09-06 1985-09-05 腫瘍治療剤およびその製法

Country Status (13)

Country Link
EP (1) EP0173951B1 (en:Method)
JP (1) JPS6168427A (en:Method)
AT (1) ATE64531T1 (en:Method)
CA (1) CA1277600C (en:Method)
DE (2) DE3432714A1 (en:Method)
DK (1) DK172253B1 (en:Method)
ES (1) ES8704082A1 (en:Method)
FI (1) FI88360C (en:Method)
GR (1) GR852149B (en:Method)
IE (1) IE58638B1 (en:Method)
IL (1) IL76289A (en:Method)
PT (1) PT81093B (en:Method)
ZA (1) ZA856807B (en:Method)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
AT398900B (de) * 1991-02-12 1995-02-27 Pekar Rudolf Dr Vakzine für eine immuntherapie
US6953668B1 (en) 1992-11-05 2005-10-11 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
DE69334071T2 (de) * 1992-11-05 2007-10-25 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches membranantigen
US7070782B1 (en) 1992-11-05 2006-07-04 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
US6569432B1 (en) 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
EP0812356B1 (en) 1995-02-24 2006-02-08 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
DE19506483A1 (de) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Lyophilisat-Vakzine
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
EP1448588A4 (en) 2001-10-23 2006-10-25 Psma Dev Company L L C ANTIBODIES AND MULTIMERS OF PSMA PROTEINS
CN1315536C (zh) * 2002-09-13 2007-05-16 李进 肿瘤抗原疫苗及其制备方法和疫苗组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
DE2643215A1 (de) * 1976-09-25 1978-04-06 Bayer Ag Cancerostatisch wirksame praeparationen aus tumorzellen und ein verfahren zu ihrer herstellung
ZA776822B (en) * 1976-11-24 1979-06-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease
DE2918927A1 (de) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
IL76289A (en) 1992-01-15
EP0173951B1 (de) 1991-06-19
ES8704082A1 (es) 1987-03-16
DK402485A (da) 1986-03-07
ATE64531T1 (de) 1991-07-15
FI853389L (fi) 1986-03-07
EP0173951A3 (en) 1988-06-08
FI853389A0 (fi) 1985-09-04
FI88360B (fi) 1993-01-29
ES546701A0 (es) 1987-03-16
IL76289A0 (en) 1986-01-31
CA1277600C (en) 1990-12-11
EP0173951A2 (de) 1986-03-12
DK172253B1 (da) 1998-02-09
ZA856807B (en) 1986-04-30
DK402485D0 (da) 1985-09-03
FI88360C (fi) 1993-05-10
PT81093B (pt) 1988-07-01
DE3432714A1 (de) 1986-04-24
GR852149B (en:Method) 1986-01-03
PT81093A (de) 1985-10-01
IE852191L (en) 1986-03-06
DE3583265D1 (de) 1991-07-25
IE58638B1 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
EP0006916B1 (en) Immunological preparations incorporating mhc antigens and their production
US4550019A (en) Manufacture and use of fowl egg antibodies
Hopper et al. Recongnition by guinea-pig peritoneal exudate cells of conformationally different states of the collagen molecule
Steffen et al. Immunogenicity and specificity of collagen: V. Demonstration of three different antigenic determinants on calf collagen
US4816253A (en) Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
JPS6168427A (ja) 腫瘍治療剤およびその製法
JPH07508498A (ja) スタフィロコッカス・エピダーミジス関連ｉ及びｉｉ型表面抗原
US4567041A (en) Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
Fuchs et al. Immunological studies of plant hormones: detection and estimation by immunological assays
JPS58500948A (ja) 「う」蝕症からの保護
CN1046291C (zh) Rib蛋白、其纯化方法、检测试剂盒及药物组合物
RU2163243C2 (ru) Белки из печени козы, обладающие противоопухолевой активностью, фармацевтическая композиция
Hasløv et al. Biological activity in sensitized guinea pigs of MPB 70, a protein specific for some strains of Mycobacterium bovis BCG
JPS62501189A (ja) 腫瘍↓−胎児に特異的なモノクロナ−ル抗体の調製方法および使用方法
Kjeilén Reactions between adenovirus antigens and papain digested rabbit immune globulin
CN117264904A (zh) 一种靶向HER2的γδT细胞及其制备方法与应用
JPS6042398A (ja) ムラミルジペプチド活性エステル誘導体
SU792869A1 (ru) Способ получени конъюгированных антигенов барбитурова кислота-иммуногенный носитель
JPS62502193A (ja) 抗原、抗体およびその用途
US6294172B1 (en) Monoclonal antibodies with specificity for membrane-associated antigens
JPH05506241A (ja) ３５ｋｄ腫瘍関連タンパク質抗原および免疫複合体
Friedman et al. A 50 s ribosomal determinant: Immunological studies correlating function and structure
CN116854778A (zh) 一种lncRNA UPK1A-AS1的抗体及其制备方法与应用
JPH02135098A (ja) Ｎ−グリコリル型ｇｍ↓２を認識するモノクローナル抗体及びそれを産生するハイブリドーマ
CN105777873A (zh) 一种含有碳氮键的His-Vx3-eGFP蛋白-纳米铝共价偶联泛素化蛋白及其提取方法和应用